Martin-Broto, J., et al. Nivolumab and sunitinib combination in advanced soft tissue sarcomas: a multicenter, single-arm, phase Ib/II trial. J Immunother Cancer 2020; 8:e001561. doi: 10.1136/jitc-2020-001561
Goswami, S., et al. ARID1A mutation plus CXCL13 expression act as combinatorial biomarkers to predict responses. Sci. Transl. Med. 12, eabc4220 (2020) 17 Jun 2020.
Page last updated September 29, 2022